to Banking & Insurance (H)
Summary
The bill tells health insurers, pharmacy‑benefit managers and similar administrators to calculate a patient’s out‑of‑pocket cost for a drug after subtracting at least 85% of any rebates they receive. Any leftover rebates must be used to lower health‑plan premiums, while the exact rebate amounts are treated as trade secrets. It also bars these administrators from charging patients more than the drug’s cash price.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HB 512 changes status, plus AI-powered summaries and stage predictions.
Sign up free